A clinician talking into her phone on a walk outside the clinic
Product strategy

Doctors tell your MSLs what they need. Most of it never gets used.

Medical science liaisons hear what doctors need every day. Most of it goes into CRM notes that someone reads months later. A short voice debrief after each visit gets it to medical and commercial teams the same week.

Doctors are willing to talk. 98% of KOLs are open to sharing insights with biopharma, and only 30% of medical insights get used (Veeva, 2026).

So the conversations are happening. The insight gets lost between the visit and the people who could act on it.

Where it goes

An MSL finishes a visit and writes a CRM note. Medical and commercial teams see what the doctor said when someone reads those notes, often months later.

A structured field doesn't fix this. It captures answers to the questions you thought to ask. The thing a doctor brings up unprompted is usually the part worth hearing, and it has no field.

A voice debrief after each visit

We add a short voice debrief through Roux, the AI interviewer we built. The MSL talks on their own phone, and the conversation asks follow-up questions the way a good interviewer would.

What comes back is grouped into themes, each with the quotes behind it and how many people raised it. Medical and commercial teams see what MSLs heard that week, in one place.

Your team gets the transcripts as well as the themes, and decides who sees them.

Medical education has the same gap

In 2025, 39% of accredited CME activities measured learner performance (ACCME Data Report, 2026). Most providers can report who finished a course and little about what learners changed afterward.

Short voice conversations after a course get hundreds of learners to respond in the same week, so the next course answers what they asked for.

Ask again next quarter

One round tells you where things stand today. Asking the same questions every quarter shows what's changing among the doctors your teams serve.

There's more on our pages for pharma and biotech teams and discovery and strategy.

More writings

We'd love to chat.

Bring what's slow, rented or stuck. You'll leave with what we'd build first and how long it takes.

Book a call